Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KRAS | P01116 | 4/20 | 0.43 |
| ▸ | EGFR | P00533 | 2/20 | 0.43 |
| ▸ | HMOX2 | P30519 | 1/20 | 0.43 |
| ▸ | CRYZ | Q08257 | 1/20 | 0.43 |
| ▸ | VAT1 | Q99536 | 1/20 | 0.43 |
| ▸ | RTN4 | Q9NQC3 | 1/20 | 0.43 |
| ▸ | TNF | P01375 | 3/20 | 0.43 |
| ▸ | LITAF | Q99732 | 3/20 | 0.43 |
| ▸ | ALK | Q9UM73 | 4/20 | 0.42 |
| ▸ | MAP4K1 | Q92918 | 1/20 | 0.41 |
| ▸ | MAPT | P10636 | 2/20 | 0.40 |
| ▸ | GPR119 | Q8TDV5 | 1/20 | 0.40 |
| ▸ | SUV39H2 | Q9H5I1 | 2/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21136787 | 0.93 | KRAS (0.44) | KRASTNFLITAFALKMAP4K1 | |
| SCHEMBL16637000 | 0.91 | KRAS (0.44) | KRASEGFRHMOX2CRYZVAT1 | |
| SCHEMBL18395526 | 0.89 | MAPT (0.57) | MAPT | |
| SCHEMBL16637040 | 0.87 | KRAS (0.59) | KRASEGFRHMOX2CRYZVAT1 | |
| SCHEMBL21136910 | 0.84 | ALK (0.40) | TNFLITAFALKMAPTGPR119 | |
| SCHEMBL18153432 | 0.84 | CXCR2 (0.39) | KRASEGFRHMOX2CRYZVAT1 | |
| SCHEMBL18128388 | 0.84 | KRAS (0.45) | KRASEGFRHMOX2CRYZVAT1 | |
| SCHEMBL31657979 | 0.84 | KRAS (0.45) | KRASEGFRHMOX2CRYZVAT1 | |
| SCHEMBL18153434 | 0.83 | KRAS (0.41) | KRASEGFRHMOX2CRYZVAT1 | |
| SCHEMBL21099583 | 0.83 | KRAS (0.63) | KRASTNFLITAFALK |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2019110751-A1 | TETRACYCLIC COMPOUNDS AS INHIBITORS OF G12C MUTANT RAS PROTEIN, FOR USE AS ANTI-CANCER AGENTS | ASTRAZENECA AB (SE) | 2019-06-13 | — | — | WO | disclosed |